Gabavolt NT 37.5 Tablet SR
Marketer
Neomac Pharmaceuticals Pvt Ltd
Salt Composition
Pregabalin (37.5mg) + Nortriptyline (10mg)
Overview Gabavolt NT 37.5 Tablet SR
Neuropathic pain relief is provided by the extended-release Gabavolt NT 37.5mg tablet, a combination drug. This medication reduces pain by interrupting pain signal transmission to the brain. Gabavolt NT 37.5mg tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should only occur with your doctor's guidance. Common side effects include constipation, urinary difficulties, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may also occur; avoid activities requiring alertness until the effects are known. Weight gain may be experienced; mitigate this through regular exercise and a balanced diet. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Prior to commencing treatment, inform your physician of any kidney or liver conditions, and provide a comprehensive list of all other medications you are currently using, as interactions may affect efficacy or functionality. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Gabavolt NT 37.5 Tablet SR
No text provided to rephrase.
Uses of Gabavolt NT 37.5 Tablet SR
Managing neuropathic pain
Major Benefits of Gabavolt NT 37.5 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gabavolt NT 37.5 SR Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets can be taken with or without food, though consistent timing is recommended.
Common Side effects of Gabavolt NT 37.5 Tablet SR:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Gabavolt NT 37.5 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gabavolt NT 37.5 Tablet SR whole; avoid chewing, crushing, or breaking it. While this extended-release tablet can be taken with or without food, consistent timing is recommended for optimal results.
How Gabavolt NT 37.5 Tablet SR works:
Gabavolt NT 37.5 SR tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain transmission by modulating nerve cell activity. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal propagation within the central nervous system. This dual mechanism effectively targets nerve damage-induced pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gabavolt NT 37.5 SR tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
The use of Gabavolt NT 37.5 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Gabavolt NT 37.5mg tablets are likely not suitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Gabavolt NT 37.5 Tablet SR, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with kidney impairment should use Gabavolt NT 37.5 mg sustained-release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Gabavolt NT 37.5 SR tablets appear to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Gabavolt NT 37.5 Tablet SR :
Should you forget to take a Gabavolt NT 37.5 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gabavolt NT 37.5 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Neuroscience, Central Nervous System |



